We report six HIV patients who developed painful periungual inflammation of
several nails during treatment with the antiretroviral drugs indinavir and
lamivudine. The lesions appeared 2-12 months after starting treatment. The
occurrence of paronychia in HIV patients has recently been reported in two
groups of patients receiving either indinavir or lamivudine. Dermatologist
s should be aware of this recently reported and probably not uncommon side-
effect of antiretroviral treatment in order to avoid an invasive approach t
o the nail lesions.